Mitch Raponi

Mitch Raponi

Company: BeiGene

Job title: Vice President, Biomarkers & Translational Research


Mitch Raponi, PhD, is Vice President of Biomarker Development & Translational Research at BeiGene. He is responsible for designing and executing companion diagnostic strategies to support the development and commercialization of the companies immune-oncology and targeted cancer therapeutic pipeline. Mitch was previously VP of Molecular Diagnostics at Clovis Oncology where his work led to the development and approval of the first NGS-based companion diagnostics for the PARP inhibitor, rucaparib. Prior to this Mitch spent 15 years at Johnson & Johnson building biomarker and companion diagnostic programs within the diagnostics and pharmaceutical franchises. He received his PhD in Molecular Genetics and Biochemistry from the University of New South Wales, Australia, and has published in the fields of gene therapy, cancer genomics, and personalized medicine. 



Panel Discussion: Patient Stratification & Biomarker Strategy 10:10 am

Read more

day: Day Two

On the Cutting-Edge of PARPi 9:30 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.